Characterization of Ser338 phosphorylation for Raf-1 activation

Area of Science:

• Molecular Biology
• Cell Signaling
• Oncology

Background:

• Raf kinases are crucial regulators of cell proliferation, survival, and tumorigenesis.
• Understanding Raf kinase activation mechanisms is vital, with phosphorylation playing a key role in response to mitogens.

Purpose of the Study:

• To characterize the phosphorylation of Serine 338 (Ser338), a critical event for Raf-1 activation.
• To investigate the mechanisms and signaling pathways involved in Raf-1 Ser338 phosphorylation.

Main Methods:

• Site-directed mutagenesis of Raf-1 (e.g., Lys375 to Met, Ser471 to Ala) and B-Raf.
• Cell treatment with epidermal growth factor (EGF), 12-O-tetradecanoylphorbol-13-acetate (TPA), Sorafenib, and U0126.
• Analysis of protein phosphorylation and dimerization using kinase-dead mutants and artificial dimerization.

Main Results:

• Mutation of Lys375 to Met diminished Ser338 phosphorylation in response to EGF/TPA.
• Ser338 phosphorylation was abolished by mutation of Ser471 to Ala, but not by kinase-dead mutations when phosphorylated by Pak1.
• EGF-stimulated Ser338 phosphorylation was inhibited by Sorafenib but not U0126, and Ser445 on B-Raf was also affected.
• Inactive Raf-1 is phosphorylated on Ser338 by active Raf-1 upon dimerization, leading to ERK1/2 activation.

Conclusions:

• Ser338 on Raf-1 is autophosphorylated in response to mitogens, representing a key regulatory event in Raf activation.
• Raf kinase dimerization is essential for Ser338 autophosphorylation and subsequent signaling.
• These findings provide insights into Raf kinase regulation and potential therapeutic targets in cancer.